Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Nature

• Publication date

  1999-04-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/19077PMID 10206644
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease.

  1999cited by this paper
• A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain

  1999cited by this paper
• Subcellular Distribution and Turnover of Presenilins in Transfected Cells*

  1998cited by this paper
• Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans.

  1998cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain

  1998cited by this paper
• Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins.

  1998cited by this paper
• Presenilin 1 regulates the processing of β-amyloid precursor protein C- terminal fragments and the generation of amyloid β-protein in endoplasmic reticulum and Golgi

  1998cited by this paper
• The Proteolytic Fragments of the Alzheimer’s Disease-associated Presenilin-1 Form Heterodimers and Occur as a 100–150-kDa Molecular Mass Complex*

  1998cited by this paper
• A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity.

  1998cited by this paper
• Caspase‐mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling

  1998cited by this paper
• A Substrate-Based Difluoro Ketone Selectively Inhibits Alzheimer's γ-Secretase Activity

  1998cited by this paper
• Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.

  1998cited by this paper
• The Alzheimer family of diseases: many etiologies, one pathogenesis?

  1997cited by this paper
• HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling.

  1997cited by this paper
• Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm

  1997cited by this paper
• Evidence That Levels of Presenilins (PS1 and PS2) Are Coordinately Regulated by Competition for Limiting Cellular Factors*

  1997cited by this paper
• Modulation of Ras and a-Factor Function by Carboxyl-Terminal Proteolysis

  1997cited by this paper
• Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.

  1997cited by this paper
• Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.

  1997cited by this paper
• Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs.

  1997cited by this paper
• Skeletal and CNS defects in Presenilin-1-deficient mice.

  1997cited by this paper
• Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins*

  1997cited by this paper
• Assessment of normal and mutant human presenilin function in Caenorhabditis elegans.

  1996cited by this paper
• Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein.

  1996cited by this paper
• Alzheimer–associated presenilins 1 and 2 : Neuronal expression in brain and localization to intracellular membranes in mammalian cells

  1996cited by this paper
• Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo.

  1996cited by this paper
• Evidence that production and release of amyloid beta-protein involves the endocytic pathway.

  1994cited by this paper
• Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease.

  1994cited by this paper
• Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions

  1992cited by this paper
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.

  1992cited by this paper
• Amyloid β-peptide is produced by cultured cells during normal metabolism

  1992cited by this paper
• Molecular biology of adrenergic and muscarinic cholinergic receptors. A perspective.

  1989cited by this paper

• Aggregation-dependent epitope sequence and modification fingerprints of anti-Aβ antibodies.

  2026cites this paper
• Presenilin-1 Familial Alzheimer Mutations Impair γ-Secretase Cleavage of APP Through Stabilized Enzyme–Substrate Complex Formation

  2025cites this paper
• A Change of Mind: Targeting Amyloid-β with Better Safety Profile.

  2025cites this paper
• Pathological Mechanism of Alzheimer's Disease, Progress in Drug Development and Future Prospects

  2025cites this paper
• Induced Microglial-like Cells Derived from Familial and Sporadic Alzheimer’s Disease Peripheral Blood Monocytes Show Abnormal Phagocytosis and Inflammatory Response to PSEN1 E280A Cholinergic-like Neurons

  2025cites this paper
• Presenilin Loss Impairs Synaptic Transmission and Causes Axonal Degeneration through Ryanodine Receptor Dysfunction, Independent of γ-Secretase Activity

  2025cites this paper
• Interactions between daily sleep-wake rhythms, γ-secretase, and amyloid-β peptide pathology point to complex underlying relationships.

  2025cites this paper
• MtDNA‐depleted neuronal cell transcriptomes reveal Alzheimer's disease‐related changes

  2025cites this paper
• Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models

  2025cites this paper
• Determinants for Substoichiometric Inhibition of IAPP and Aβ Amyloid Aggregations by Bri2 BRICHOS.

  2025cites this paper
• Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers

  2025cites this paper
• A unique subpopulation of wild-type neurons recapitulating familial Alzheimer’s disease phenotypes

  2025cites this paper
• γ-Secretase-mediated endoproteolysis of neuregulin-1 and E-cadherin

  2025cites this paper
• Insights into the intramembrane protease SPPL2b and its substrates: Functions and disease implications.

  2025cites this paper
• Targeting the PS1-ELK1 protein-protein interaction with a peptide-based inhibitor reduces Aβ production and alleviates memory decline in Alzheimer's disease.

  2025cites this paper
• The curious case of a heterozygous loss-of-function PSEN1 variant associated with early-onset Alzheimer’s disease

  2025cites this paper
• Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers.

  2025cites this paper
• Presenilin, γ-Secretase, and the Search for Pathogenic Triggers of Alzheimer's Disease.

  2025cites this paper
• Chloroplast Members of the S2P Proteases Family, AraSP and AtS2P2, May Have a Functional Relationship in Promoting Plant Growth

  2025cites this paper
• Implications of mitochondrial phosphatidylethanolamine in neuronal health and neurodegeneration.

  2025cites this paper
• REVOLUTIONIZING ALZHEIMER’S THERAPEUTICS: FROM MICROTECHNOLOGIES TO AI-DRIVEN INNOVATIONS

  2025cites this paper
• A Sensitive and Versatile Cell‐Based Assay Combines Luminescence and Trapping Approaches to Monitor Unconventional Protein Secretion

  2025cites this paper
• γ-secretase targeting in Alzheimer's disease

  2025cites this paper
• γ-Secretase exosites as targets for substrate-selective lowering of Aβ generation.

  2025cites this paper
• Demyelination-induced glutamatergic imbalance mediates hippocampal Hyperexcitability.

  2025cites this paper
• Structural insights into human signal peptide peptidase.

  2025cites this paper
• The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease

  2025cites this paper
• Presenilin mutations disrupt iron homeostasis to promote ferroptosis mediated neurodegeneration in Caenorhabditis elegans

  2025cites this paper
• Aggregation-Dependent Epitope Sequence and Modification Fingerprints of Anti-Aβ Antibodies

  2025cites this paper
• The connection between autophagy and Alzheimer’s disease

  2025cites this paper
• Advances in non-human primate models for Alzheimer's disease research.

  2025cites this paper
• APP family is a regulator of endo-lysosomal membrane vulnerability

  2025cites this paper
• Endogenous γ-Secretase Is Linked to Phagocytic Activity in Microglial Cells

  2025cites this paper
• Effects of transmembrane phenylalanine residues on γ-secretase-mediated Notch-1 proteolysis

  2024cites this paper
• Comprehensive investigation of multiple targets in the development of newer drugs for the Alzheimer's disease

  2024cites this paper
• C-terminal amino acids in the type I transmembrane domain of L-type lectin VIP36 affect γ-secretase susceptibility.

  2024cites this paper
• The pathogenicity of PSEN2 variants is tied to Aβ production and homology to PSEN1

  2024cites this paper
• Negative Regulation of Cathepsins by β-Amyloid

  2024cites this paper
• Identification of novel risk genes for Alzheimer’s disease by integrating genetics from hippocampus

  2024cites this paper
• Recording γ-secretase activity in living mouse brains

  2024cites this paper
• Selective Protonation of Catalytic Dyad for γ-Secretase-Mediated Hydrolysis Revealed by Multiscale Simulations

  2024cites this paper
• GNG5 is a novel regulator of Aβ42 production in Alzheimer’s disease

  2024cites this paper
• Examining nirogacestat for adults with progressing desmoid tumors who require systemic treatment

  2024cites this paper
• The Amyloid Cascade Hypothesis: A Conclusion in Search of Support.

  2024cites this paper
• An electrostatic cluster guides Aβ40 fibril formation in sporadic and Dutch-type cerebral amyloid angiopathy

  2024influential citation
• New precision medicine avenues to the prevention of Alzheimer’s disease from insights into the structure and function of γ-secretases

  2024cites this paper
• Predicting hotspots for disease-causing single nucleotide variants using sequences-based coevolution, network analysis, and machine learning

  2024cites this paper
• The advent of Alzheimer treatments will change the trajectory of human aging

  2024cites this paper
• Identification of PS1/gamma-secretase and glutamate transporter GLT-1 interaction sites

  2024cites this paper
• PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease

  2024cites this paper
• Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer’s Disease

  2024cites this paper
• Presenilin Deficiency Results in Cellular Cholesterol Accumulation by Impairment of Protein Glycosylation and NPC1 Function

  2024cites this paper
• Understanding the Modulatory Role of E2012 on the γ-Secretase-Substrate Interaction

  2024cites this paper
• Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects

  2024cites this paper
• Amyloid-independent pathogenesis for Alzheimer’s disease: implications for drug design

  2024cites this paper
• Substrate Selection Criteria in Regulated Intramembrane Proteolysis.

  2024cites this paper
• Behavioural pharmacology predicts disrupted signalling pathways and candidate therapeutics from zebrafish mutants of Alzheimer’s disease risk genes

  2024cites this paper
• The case for regulatory approval of amyloid‐lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence

  2024cites this paper
• Discovery of anticancer compound possessing potential to bind γ-secretase catalytic subunit and inhibit notch promoter activity

  2024cites this paper
• Pathophysiologic abnormalities in transgenic mice carrying the Alzheimer disease PSEN1 Δ440 mutation.

  2024cites this paper
• Presenilin: A Multi-Functional Molecule in the Pathogenesis of Alzheimer’s Disease and Other Neurodegenerative Diseases

  2024cites this paper
• An Overview of the Genes and Biomarkers in Alzheimer's Disease.

  2024cites this paper
• Generation and Characterization of a Novel Knockin Mouse Model Expressing PSEN1 D385A: Implications for Investigating Herbal Drug Effects in γ-Secretase Activity

  2024influential citation
• Potentially Pathogenic SORL1 Mutations Observed in Autosomal-Dominant Cases of Alzheimer’s Disease Do Not Modulate APP Physiopathological Processing

  2023cites this paper
• Surface plasmon resonance as a fascinating approach in target-based drug discovery and development

  2023cites this paper
• Emerging evidence for dysregulated proteome cargoes of tau-propagating extracellular vesicles driven by familial mutations of tau and presenilin

  2023cites this paper
• Functional and topological analysis of PSENEN, the fourth subunit of the γ-secretase complex

  2023cites this paper
• The amyloid-β peptide: Guilty as charged?

  2023cites this paper
• Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine.

  2023cites this paper
• PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease

  2023cites this paper
• Structure and function of SPP/SPPL proteases: insights from biochemical evidence and predictive modeling

  2023cites this paper
• Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1

  2023cites this paper
• Molecular Dynamics Activation of γ-Secretase for Cleavage of Notch1 Substrate

  2023cites this paper
• Identification of PS1/gamma-secretase and glutamate transporter GLT-1 interaction sites

  2023cites this paper
• Glycogen synthase kinase 3β (GSK3β) and presenilin (PS) are key regulators of kinesin-1-mediated cargo motility within axons

  2023cites this paper
• Differential effects of familial Alzheimer’s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity

  2023cites this paper
• Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia

  2023cites this paper
• Selective inhibitors of the PSEN1–gamma-secretase complex

  2023cites this paper
• Differential and substrate-specific inhibition of γ-secretase by the C-terminal region of ApoE2, ApoE3, and ApoE4.

  2023cites this paper
• Structure-activity relationship of BMS906024 derivatives for Cryptosporidium parvum growth inhibition

  2023cites this paper
• Probing the Mechanisms of Inhibitors Binding to Presenilin Homologue Using Molecular Dynamics Simulations

  2023cites this paper
• Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia

  2023cites this paper
• Endosome and Lysosome Membrane Properties Functionally Link to γ-Secretase in Live/Intact Cells

  2023cites this paper
• Different transmembrane domains determine the specificity and efficiency of the cleavage activity of the γ-secretase subunit presenilin

  2023cites this paper
• Cascade autohydrolysis of Alzheimer's Aβ peptides

  2023cites this paper
• Cordyceps cicadae NTTU 868 Mycelia Fermented with Deep Ocean Water Minerals Prevents D-Galactose-Induced Memory Deficits by Inhibiting Oxidative Inflammatory Factors and Aging-Related Risk Factors

  2023cites this paper
• Mitofusin-2: Functional Switch Between Mitochondrial Function And Neurodegeneration.

  2023cites this paper
• Effects of presenilin-1 familial Alzheimer’s disease mutations on γ-secretase activation for cleavage of amyloid precursor protein

  2023cites this paper
• Specific Mutations near the Amyloid Precursor Protein Cleavage Site Increase γ-Secretase Sensitivity and Modulate Amyloid-β Production

  2023influential citation
• The transmembrane domain of Frey1 harbors a transplantable inhibitory motif for intramembrane proteases

  2023cites this paper
• Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease

  2023cites this paper
• Enzyme-substrate hybrid β-sheet controls geometry and water access to the γ-secretase active site

  2023cites this paper
• Cholinergic-like neurons and cerebral spheroids bearing the PSEN1 p.Ile416Thr variant mirror Alzheimer's disease neuropathology

  2023cites this paper
• Discovery of brain permeable 2-Azabicyclo[2.2.2]octane sulfonamides as a novel class of presenilin-1 selective γ-secretase inhibitors.

  2023cites this paper
• Unveiling the Molecular Footprint: Proteome-Based Biomarkers for Alzheimer’s Disease

  2023cites this paper
• An electrostatic cluster guides Aβ40 fibril formation in cerebral amyloid angiopathy

  2023cites this paper
• Mechanistic regulation of γ-secretase by their substrates.

  2022cites this paper
• In-Depth Characterization of Endo-Lysosomal Aβ in Intact Neurons

  2022cites this paper
• Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides

  2022cites this paper
• Notch signaling in malignant gliomas: supporting tumor growth and the vascular environment

  2022cites this paper